Wealth Dimensions Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$210K Buy
427
+27
+7% +$14.7K 0.04% 163
2025
Q4
$232K Sell
400
-200
-33% -$113K 0.05% 150
2025
Q3
$291K Sell
600
-67
-10% -$31.2K 0.06% 135
2025
Q2
$270K Hold
667
0.06% 140
2025
Q1
$332K Hold
667
0.08% 119
2024
Q4
$347K Buy
667
+263
+65% +$145K 0.09% 111
2024
Q3
$250K Buy
404
+2
+0.5% +$1.18K 0.06% 128
2024
Q2
$222K Buy
402
+32
+9% +$18.3K 0.06% 132
2024
Q1
$215K Buy
+370
New +$208K 0.06% 133
2023
Q2
Sell
-370
Closed -$213K 138
2023
Q1
$213K Hold
370
0.08% 126
2022
Q4
$204K Buy
+370
New +$196K 0.08% 126
2022
Q3
Sell
-373
Closed -$203K 125
2022
Q2
$203K Buy
373
+10
+3% +$5.5K 0.1% 122
2022
Q1
$214K Sell
363
-17
-4% -$9.77K 0.1% 124
2021
Q4
$254K Hold
380
0.12% 117
2021
Q3
$217K Buy
+380
New +$209K 0.14% 118

Other funds holding TMO

Wealth Dimensions Group's TMO Position: Q1 2026 in Review

Wealth Dimensions Group increased its Thermo Fisher Scientific (TMO) stake by 6.8% in Q1 2026, buying an estimated $14.7K and bringing the position to 427 shares worth $210K. The position accounts for 0.04% of the portfolio, ranked #163.

Wealth Dimensions Group first reported a position in TMO in Q3 2021 and has held it in 15 quarters since. The position peaked at $347K in Q4 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Wealth Dimensions Group held 427 shares of Thermo Fisher Scientific worth $210K as of Q1 2026.
  • Wealth Dimensions Group bought 27 Thermo Fisher Scientific shares in Q1 2026, an estimated $14.7K.
  • Thermo Fisher Scientific made up 0.04% of Wealth Dimensions Group's portfolio in Q1 2026, its #163 holding.
  • Wealth Dimensions Group first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 15 quarters since.
  • Wealth Dimensions Group's Thermo Fisher Scientific position peaked at $347K in Q4 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Wealth Dimensions Group's 13F filing for Q1 2026, filed 12 May 2026.